341 related articles for article (PubMed ID: 33125126)
1. Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).
He R; Du S; Lei T; Xie X; Wang Y
Oncol Rep; 2020 Dec; 44(6):2373-2385. PubMed ID: 33125126
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
3. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.
Sahin I; Eturi A; De Souza A; Pamarthy S; Tavora F; Giles FJ; Carneiro BA
Cancer Biol Ther; 2019; 20(8):1047-1056. PubMed ID: 30975030
[TBL] [Abstract][Full Text] [Related]
5. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer.
Lin J; Song T; Li C; Mao W
Biochim Biophys Acta Mol Cell Res; 2020 May; 1867(5):118659. PubMed ID: 31978503
[TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis.
Zheng H; Yang Z; Xin Z; Yang Y; Yu Y; Cui J; Liu H; Chen F
Theranostics; 2020; 10(25):11737-11753. PubMed ID: 33052244
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19
Li J; Gao J; Zhou H; Zhou J; Deng Z; Lu Y; Rao J; Ji G; Gu J; Yang X; Xia Y; Wang X
Front Immunol; 2020; 11():603288. PubMed ID: 33343576
[TBL] [Abstract][Full Text] [Related]
10. The role of glycogen synthase kinase 3 beta in multiple sclerosis.
Noori T; Dehpour AR; Sureda A; Fakhri S; Sobarzo-Sanchez E; Farzaei MH; Küpeli Akkol E; Khodarahmi Z; Hosseini SZ; Alavi SD; Shirooie S
Biomed Pharmacother; 2020 Dec; 132():110874. PubMed ID: 33080467
[TBL] [Abstract][Full Text] [Related]
11. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.
Darshit BS; Ramanathan M
Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.
Walz A; Ugolkov A; Chandra S; Kozikowski A; Carneiro BA; O'Halloran TV; Giles FJ; Billadeau DD; Mazar AP
Clin Cancer Res; 2017 Apr; 23(8):1891-1897. PubMed ID: 28053024
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of glycogen synthase kinase-3β in Alzheimer's disease: a novel therapeutic target.
Mandlik DS; Mandlik SK; S A
Int J Neurosci; 2024 Jun; 134(6):603-619. PubMed ID: 36178363
[TBL] [Abstract][Full Text] [Related]
16. Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
Hulcová D; Breiterová K; Siatka T; Klímová K; Davani L; Šafratová M; Hošťálková A; De Simone A; Andrisano V; Cahlíková L
Molecules; 2018 Mar; 23(4):. PubMed ID: 29561817
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
19. Glycogen Synthase Kinase-3β Facilitates Cytokine Production in 12-O-Tetradecanoylphorbol-13-Acetate/Ionomycin-Activated Human CD4
Tsai CC; Tsai CK; Tseng PC; Lin CF; Chen CL
Cells; 2020 Jun; 9(6):. PubMed ID: 32521784
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer.
Nagini S; Sophia J; Mishra R
Semin Cancer Biol; 2019 Jun; 56():25-36. PubMed ID: 29309927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
